Pasteurized C1 inhibitor concentrate in hereditary angioedema: Pharmacology, safety, efficacy and future directions

Expert Review of Clinical Immunology

Volumn 4, Issue 1, 2008, Pages 13-20

  Bork, Konrad ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Angioedema; Berinert P; C1 inhibitor deficiency; Hereditary angiodema; Pasteurized C1 inhibitor concentrate

Indexed keywords

ANDROGEN; BERINERT P; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; CETOR; COMPLEMENT COMPONENT C1S; COMPLEMENT COMPONENT C1S INHIBITOR; DANAZOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DX 88; ESTROGEN DERIVATIVE; FRESH FROZEN PLASMA; ICATIBANT; KALLIKREIN; KALLIKREIN INHIBITOR; PLACEBO; SPASMOLYTIC AGENT; STANOZOLOL; TRANEXAMIC ACID;

ABDOMINAL PAIN; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; CHILL; CLINICAL FEATURE; CLINICAL TRIAL; DEPRESSION; DIARRHEA; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FAINTNESS; FATIGUE; GENETIC DISORDER; HUMAN; LARYNX EDEMA; LIPID BLOOD LEVEL; LIVER TUMOR; MENSTRUAL IRREGULARITY; MORTALITY; MYALGIA; NAUSEA; NONHUMAN; POSTMARKETING SURVEILLANCE; PREVALENCE; PROTEIN SYNTHESIS INHIBITION; RISK REDUCTION; SIDE EFFECT; SKIN SWELLING; VIRILIZATION; VIRUS INFECTION; VOMITING; WEIGHT GAIN;

EID: 46149105006     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/1744666X.4.1.13     Document Type: Article

References (62)

1. Quincke HI. Ueber akutes umschriebenes Hautoedem. Monatsh. Prakt. Dermatol. 1, 129-131 (1882).
2. Osler W. Hereditary angioneurotic edema. Am. J. Med. Sci. 95, 362-367 (1888).
3. Donaldson VH, Evans RR. A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C'1-esterase. Am. J. Med. 35, 37-44 (1963).
4. Rosen FS, Pensky J, Donaldson V, Charache P. Hereditary angioneurotic edema: two genetic variants. Science 148, 957-958 (1965).
5. Bowen B, Hawk JJ, Sibunka S, Hovick S, Weiler JM. A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations. Clin. Immunol. 98(2), 157-163 (2001).
6. Kalmar I., Bors A, Farkas H et al. Mutation screening of the C1 inhibitor gene among Hungarian patients with hereditary angioedema. Hum. Mutat. 22(6), 498 (2003).
7. Drouet C, Blanch A, Roche O et al. HAE: Mutation analysis of the C1INH gene. J. Allergy Clin. Immunol. 114, S66-S74 (2004).
8. Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore) 71(4), 206-215 (1992).
9. Bork K, Barnstedt SE, Koch P, Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 356(9225), 213-217 (2000).
10. Dewald G, Bork K. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem. Biophys. Res. Commun. 343(4), 1286-1289 (2006).
11. Bork K. Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations. Immunol. Allergy Clin. North Am. 26(4), 709-724 (2006).
12. Longhurst HJ, Bork K. Hereditary angioedema: causes, manifestations and treatment. Br. J. Hosp. Med (London) 67(12), 654-657 (2006).
13. Bork K, Staubach P, Eckardt AJ, Hardt J. Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am. J. Gastroenterol. 101(3), 619-627 (2006).
14. Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am. J. Med. 119(3), 267-274 (2006).
15. Bork K, Barnstedt SE. Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema. J. Am. Dent. Assoc. 134(8), 1088-1094 (2003).
16. Cicardi M, Zingale L. How do we treat patients with hereditary angioedema. Transfus. Apher. Sci. 29(3), 221-227 (2003).
17. Bork K. Current treatment of HAE and future treatment options. J. Allergy Clin. Immunol. 114, S94-S96 (2004).
18. Bowen T, Cicardi M, Farkas H et al. Canadian 2003 international consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema. J. Allergy Clin. Immunol. 114(3), 629-637 (2004).
19. Brackertz D, Kueppers F. Hereditary angioneurotic oedema. Lancet 2(7830), 680 (1973).
20. Gadek JE, Hosea SW, Gelfand JA et al. Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor. N. Engl. J. Med. 302(10), 542-546 (1980).
21. Waytes AT, Rosen FS, Frank MM. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. N. Engl. J. Med. 334(25), 1630-1634 (1996).
22. Kunschak M, Engl W, Maritsch F et al. A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema. Transfusion 38(6), 540-549 (1998).
23. Visentin DE, Yang WH, Karsh J. C1-esterase inhibitor transfusions in patients with hereditary angioedema. Ann. Allergy Asthma Immunol. 80(6), 457-461 (1998).
24. Bork K, Barnstedt SE. Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedcma. Arch. Intern. Med. 161(5), 714-718 (2001).
25. Bork K, Meng G, Staubach P, Hardt J. Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema. Transfusion 45(11), 1774-1784 (2005).
26. Levi M, Choi G, Picavet C, Hack CE. Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. J. Allergy Clin. Immunol. 117(4), 904-908 (2006).
27. Gompels MM, Lock RJ, Abinun M et al. C1 inhibitor deficiency: consensus document. Clin. Exp. Immunol. 139(3), 379-394 (2005).
28. Longhurst HJ. Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: what is the evidence? Int. J. Clin. Pract. 59(5), 594-599 (2005).
29. Farkas H, Gyeney L, Gidofalvy E, Fust G, Varga L. The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures. J. Oral Maxillofac. Surg. 57(4), 404-408 (1999).
30. Frank MM, Gelfand JA, Atkinson JP. Hereditary angioedema: the clinical syndrome and its management. Ann. Intern. Med. 84(5), 580-593 (1976).
31. Cicardi M, Bergamaschini L, Cugno M, Hack E, Agostoni G, Agostoni A. Longterm treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience. J. Allergy Clin. Immunol. 87(4), 768-773 (1991).
32. Frank MM. Hereditary angioedema: the clinical syndrome and its management in the United States. Immunol. Allergy Clin. North Am. 26(4), 653-668 (2006).
33. Bork K, Bygum A, Hardt J. Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. Ann. Allergy Asthma Immunol. (2007) (In press).
34. Zurlo JJ, Frank MM. The long-term safety of danazol in women with hereditary angioedema. Fertil. Steril. 54(1), 64-72 (1990).
35. Cicardi M, Castelli R, Zingale LC, Agostoni A. Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. J. Allergy Clin. Immunol. 99(2), 194-196 (1997).
36. Bork K, Schneiders V. Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema. J. Hepatol. 36(5), 707-709 (2002).
37. Szeplaki G, Varga L, Valentin S et al. Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema. J. Allergy Clin. Immunol. 115(4), 864-869 (2005).
38. De Serres J, Groener A, Lindner J. Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert P) in hereditary angioedema: a review. Transfus. Apher. Sci. 29(3), 247-254 (2003).
39. Martinez-Saguer I, Mueller W, Puersuen EA et al. Pharmacokinetic parameters of C1 inhibitor concentrate in 40 patients with hereditary angioedema (HAE) - a prospective study. Haemophilia 8, 574 (2002).
40. Bork K, Hardt J, Schickeranz KH, Ressel N. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch. Intern. Med. 163(10), 1229-1235 (2003).
41. Farkas H, Harmat G, Fust G, Varga L, Visy B. Clinical management of hereditary angio-oedema in children. Pediatr. Allergy Immunol. 13(3), 153-161 (2002).
42. Bork K, Koch P. Episodes of severe dyspnea caused by snoring-induced recurrent edema of the soft palate in hereditary angioedema. J. Am. Acad. Dermatol. 45(6), 968-969 (2001).
43. Farkas H, Jakab L, Temesszentandrasi G et al. Hereditary angioedema: a decade of human C1-inbibitor concentrate therapy. J. Allergy Clin. Immunol. 120(4), 941-947 (2007).
44. Leimgruber A, Jaques WA, Spaeth PJ. Hereditary angioedema: uncomplicated maxillofacial surgery using short-term C1 inhibitor replacement therapy. Int. Arch. Allergy Immunol. 101(1), 107-112 (1993).
45. Langton D, Weiner J, Fary W. C1-esterase inhibitor concentrate prevents upper airway obstruction in hereditary angio-oedema. Med. J. Aust. 160(6), 383-384 (1994).
46. Maves KK, Weiler JM. Tonsillectomy in a patient with hereditary angioedema after prophylaxis with C1 inhibitor concentrate. Ann. Allergy 73(5), 435-438 (1994).
47. Mohr M, Pollok-Kopp B, Gotze O, Burchardi H. The use of a C1-inhibitor concentrate for short-term preoperative prophylaxis in two patients with hereditary angioedema. Anaesthesist 45(7), 626-630 (1996).
48. Lehmann A, Lang J, Boldt J, Saggau W. Successful off-pump coronary artery bypass graft surgery in a patient with hereditary angioedema. J. Cardiothorac. Vasc. Anesth. 16(4), 473-476 (2002).
49. Bork K, Witzke G. Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency. J. Allergy Clin. Immunol. 83(3), 677-682 (1989).
50. Hermans C. Successful management with C1-inhibitor concentrate of hereditary angioedema attacks during two successive pregnancies: a case report. Arch. Gynecol. Obstet. 276(3), 271-276 (2007).
51. Juers M, Groener A. Virus safety of current plasma-derived C1-INH: the Aventis Behring experience. J. Allergy Clin. Immunol. 114, S96-S98 (2004).
52. Carugati A, Pappalardo E, Zingale LC, Cicardi M. C1-inhibitor deficiency and angioedema. Mol. Immunol. 38(2-3), 161-173 (2001).
53. Klarmann D, Kreuz W. Joseph-Steiner J, Ehrenforth S. Hepatitis C and pasteurized C1-inhibitor concentrate. Transfusion 36(1), 84-85 (1996).
54. De Filippi F, Castelli R, Cicardi M et al. Transmission of hepatitis G virus in patients with angioedema treated with steam-heated plasma concentrates of C1 inhibitor. Transfusion 38(3), 307-311 (1998).
55. Bork K. Prospective virus safety follow-up after therapy with a pasteurised C1 inhibitor concentrate. Biomed. Progr. 2, 59-61 (1992).
56. Cicardi M, Mannucci PM, Castelli R, Rumi MG, Agostoni A. Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate. Transfusion 35(3), 209-212 (1995).
57. Longhurst HJ, Carr S, Khair K. C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option. Clin. Exp. Immunol. 147(1), 11-17 (2007).
58. Zuraw BL. Novel therapies for hereditary angioedema. Immunol. Allergy Clin. North Am. 26(4), 691-708 (2006).
59. Schneider L, Lumry W, Vegh A, Williams AH, Schmalbach T. Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitor. J. Allergy Clin. Immunol. 6, 6 (2007).
60. Bork K, Frank J, Grundt B, Schlattmann P, Nussberger J, Kreuz W. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). J. Allergy Clin. Immunol. 119(6), 1497-1503 (2007).
61. Choi G, Soeters MR, Farkas H et al. Recombinant human C1-inhibitor in the treatment of acute angioedema attacks. Transfusion 47(6), 1028-1032 (2007).
62. Cicardi M, Bergamaschini L, Marasini B et al. Hereditary angioedema. an appraisal of 104 cases. Am. J. Med. Sci. 284(1), 2-9 (1982).